Broker's call: Vinati Organics (Hold)

| Updated on August 04, 2020 Published on August 05, 2020

Emkay Global

Vinati Organics (Hold)

Target: ₹1,110

CMP: ₹981.05

Vinati Organics revenues declined 21.7 per cent y-o-y, missing estimates. Globally, muted refining activity led to a 25-30 per cent y-o-y decline in ATBS (Acrylamido tertiary-butyl sulfonic acid) demand (nearly 50 per cent of sales), whereas IBB (Iso Butyl benzene) sales rose over 50 per cent y-o-y on a low base and improved demand from a key customer.

EBITDA margin remained stable y-o-y, led by a 500 bps jump in gross margin, slightly offset by high employee costs. Depreciation (up 10 per cent q-o-q) resulting from the Butylated Phenol (BP) plant commissioning (in Q3-FY20) weighed on profitability.

We believe that IBB and IB derivatives would remain strong in the near term, mitigating the muted performance in ATBS. Low demand and weak near-term outlook in ATBS could delay capacity addition (14,000 tpa). BP ramp-up may take longer-than-expected.

We believe that the stock has already priced in all the major positive factors. New products could be eyed for growth going forward.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on August 05, 2020
This article is closed for comments.
Please Email the Editor